Identification and characterization of a T cell growth inhibitory factor produced by K562 erythromyeloid cells

Cell Immunol. 1991 Nov;138(1):55-63. doi: 10.1016/0008-8749(91)90132-u.

Abstract

Cells of the human erythroleukemia cell line K562 constitutively secrete a factor that inhibits human T lymphocyte proliferation induced via CD3/Ti. The factor, termed K-TIF (K562-derived T cell inhibitory factor) is produced in either the presence or absence of fetal calf serum in cultures of K562 cells and can be precipitated by 70% NH4SO4. Gel filtration chromatography on Superose 12 resin by FPLC showed that the inhibitory factor has a molecular weight of approximately 30-35 kDa. A protein of this size, metabolically labeled with [35S]methionine, specifically bound human peripheral blood mononuclear cells. Chromatofocusing with Mono P by FPLC (pH gradient 7.2-5) indicates that the inhibitory factor has an isoelectric point of 6.0-6.4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Isoelectric Point
  • Leukemia, Erythroblastic, Acute / metabolism*
  • Lymphocyte Activation / drug effects
  • Molecular Weight
  • Suppressor Factors, Immunologic / isolation & purification*
  • Suppressor Factors, Immunologic / pharmacology
  • T-Lymphocytes / drug effects
  • Tumor Cells, Cultured

Substances

  • Suppressor Factors, Immunologic